Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Finished

OptiPlex Commercial feasibility of a cell-free reactor setup for optimisation of complex enzymatic pathways

Coordinator
Stichting Radboud Universiteit, Netherlands
Runs
1 July 2022 to 31 December 2023
Status
Finished
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101069237

What the project is doing

In the project's own words, from its summary on CORDIS.

This project will explore the commercial feasibility of the first continuous stirred tank reactor solution for the synthetic replication and optimisation of complex enzymatic pathways. Our technology provides an urgently needed alternative for bioengineered organisms. Where normally raw materials of varying quality, competition between intermediates, toxicity, complex networks of feedback loops and other poorly understood factors limit production rates, our approach can be used to converge effectively to optimised biochemistry .As part of the project, we will establish two industrially relevant pathways, advance the software solution of our platform and develop a commercialisation strategy.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Radboud UniversiteitNijmegenNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI